MIME has also been successfully used to predict the response of IBD patients to a low FODMAP diet [61] or anti-TNF treatment [62], the efficacy of synbiotic treatment of gastrointestinal disease in children [63], or the prediction of the clinical outcome of bariatric surgery [64]. This evidence concerns the gene TNF and gastrointestinal disease.